Conference detail

Global Technology Community
635 W. Foothill Blvd
Monrovia, CA 91016

phone: 626-256-6405
fax: 626-466-4433
email: infogtcbio@gtcbio.com

Dear Colleague,

We are excited to announce the 8th CNS Partnering & Deal-Making Conference, to be held September 10-11, 2015 in Philadelphia, PA.

Over the years, this partnering and business development conference has provided an opportunity for all stakeholders in the field to network and explore potential collaborations. Global biotechnology and pharmaceutical companies, patient groups and foundations, government agencies, investors, and regulatory folks have gathered to discuss partnering strategies as well as emerging research areas and trends to keep an eye on. This meeting seeks to form discussion on all topics from bench to bedside, from changing paradigm in scientific approaches in CNS disorders to partnerships for open innovation to pricing and reimbursement considerations. Colleagues will dialogue and form new relationships in order to forge a path forward into the future of neuroscience.

Day 1 Sessions and Panels (combined with Neurodegenerative Conditions R&D Conference):

1. Plenary Session: CNS: Present and Future
2. Rare and Orphan CNS Disorders
3. Alternative Funding Sources: Foundations and Public/Private Partnerships
4. Plenary Panel - topic TBD
5. Panel: Regulatory Considerations for Orphan Drug Products
6. Panel: Partnering with Patient Groups to Advance Research
7. Panel: Advances in Targeted Treatments for Neurodevelopmental Disorders

Day 2 Sessions and Panels (CNS Partnering Conference only):

1. Partnering & Licensing in CNS

2. Market Access Considerations

3. Panel: What Sells Big Pharma in CNS?

4. Panel: The Investor Vantage: CNS Opportunities from Perspective of Venture Capital and Public Markets

We hope to see you in Philadelphia!


Best regards,

The 2015 Advisory Committee